#USA #Fremont #Q'Apel Medical #Neurovascular #Stewart Strong

Q'Apel Medical Appoints Stewart Strong as New CEO

In a significant leadership shift, Q'Apel Medical has announced the appointment of Stewart Strong as its President and Chief Executive Officer. This private medical device company specializes in neurovascular interventions, aiming to revolutionize this sector. Strong's extensive experience in the medical technology industry gives him a unique position to propel the company towards its next phase of growth.

Stewart Strong is seen as the ideal choice to lead Q'Apel during this pivotal moment. R. King Nelson, the Chairman of the Board, expressed confidence in Strong's ability to drive sustainable growth through his passion for developing high-performing teams and commercial strategies. Under his leadership, the company aims to expand both its market presence and the clinical value offered to healthcare providers and patients.

Bringing more than 25 years of leadership experience in the medical device arena, Strong has cultivated high-impact teams in both publicly traded and privately held companies. His previous role as the Global President of the Hospital Business Unit at Haemonetics was marked by a significant increase in revenue due to the successful execution of corporate strategies and the introduction of innovative technologies.

Prior to his tenure at Haemonetics, Strong was the President of the Teleflex Interventional franchise, where he expanded the company's reach in interventional cardiology and radiology. His comprehensive background also includes key executive positions at Vidacare Inc., which was acquired by Teleflex in 2013, and AtriCure, Inc. Additionally, Strong has experience as a board member for Vivasure Medical and Obvius Robotics, enriching his leadership skillset.

Expressing his excitement for the new role, Strong remarked, "I am honored to assume this position and am excited to get started. Q'Apel is a leader in the neurovascular space, recognized for its innovation and customer-focused approaches. I look forward to collaborating with the Board of Directors, executive leadership, and our global team to drive growth and realize our full potential."

About Q'Apel Medical
Q'Apel Medical is at the forefront of transforming neurovascular interventions. Focused on addressing the unique clinical challenges faced by healthcare providers, the company's approach prioritizes customer feedback and innovative design. Their goal is to create advanced, high-quality, uniquely engineered products that not only meet current needs but are also adaptable for future challenges in the neurovascular field.

With the industry continually evolving, Q'Apel Medical is committed to pushing boundaries and creating solutions where others have yet to succeed. Their dedication to quality and innovation will be critical as they navigate through this leadership change under Stewart Strong's guidance.